MedTrace Logo

Investigating the Effectiveness of a Seasonal Influenza Vaccination Promotion Campaign for Members of a Non-Profit, Community-Based Health Insurance Plan: 2018-2019

NCT03700281 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22584

Last updated 2019-04-23

No results posted yet for this study

Summary

• This study will assess the effect of promotional messaging and incentives encouraging influenza vaccination in the Sendero IdealCare policy holders during the 2018-2019 Flu Season. The intervention will consist of influenza vaccination promotion/reminders from Sendero Health Plans to subscribers, including text messages, emails, and tailored direct mail outs, i.e. postcard or a personalized letter, and incentive. The study population consists of approximately 22,500 subscribers enrolled in Sendero IdealCare Plan. The intervention will last approximately four months. The primary endpoints, assessed through administrative claims data, will be getting a flu shot during the 2018-2019 season. Data collected through this study will be used to determine effective components of influenza vaccination promotion campaigns used by a health insurance plan.

Conditions

  • Influenza, Vaccination

Interventions

BEHAVIORAL

Messaging

The participants will receive influenza promotion emails, text messages, and U.S. mail from Sendero Health Plans.

BEHAVIORAL

Incentive

Participants will be eligible for a gift card to a local grocery store chain as an incentive for obtaining an influenza vaccine

Sponsors & Collaborators

  • Sendero Health Plans, Inc.

    collaborator UNKNOWN

  • The University of Texas Health Science Center at Tyler

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-06
Primary Completion
2019-03-31
Completion
2019-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03700281 on ClinicalTrials.gov